Filing of Securities Class Action
Glancy Prongay & Murray LLP, a prominent player in securities fraud litigation, has set ablaze the legal arena with the filing of a securities class action on behalf of Metagenomi, Inc. investors. Under the ticker symbol MGX on NASDAQ, the rumblings of discontent are echoing through the market.
Stock Price Volatility
On February 13, 2024, the dreamy initial public offering (IPO) day saw Metagenomi parcel out around 6.25 million shares at a price of $15 each. However, the dream took an abrupt turn just three months later. On May 1, 2024, Metagenomi and Moderna, its partner, dropped a bombshell – their collaborative venture was set to disappear into thin air.
This shocking revelation sent Metagenomi’s stock plummeting by $0.87, representing a staggering 12.4% decline, to settle at $6.17 per share by May 2, 2024.
Allegations of Misleading Statements
In clutching the reins of this class action lawsuit, the allegations are weighty. It’s claimed that throughout the Class Period, Metagenomi bigwigs were spinning a yarn of falsehoods and omissions, neglecting to disclose crucial information about the Company’s true standing. The heart of the matter seems to be the undisclosed termination of the Moderna collaboration that left investors reeling.
Legal Ramifications and Moving Forward
For those who got burned in the Metagenomi maelstrom, the window of opportunity stands open until November 25, 2024, to lodge their gripes. By swiftly snapping into action, affected investors can potentially secure a lead plaintiff role in the case. The choice to holler in the legal arena or cautiously observe from the sidelines as a silent member of the class lies in their hands.
Follow-up and Contact Details
If you find yourself entangled in the Metagenomi web, feeling the heat of your investment losses, there’s a lifeline to grasp. Reach out to Charles H. Linehan, the torchbearer of justice at GPM, through various channels – dial 310-201-9150 or the Toll-Free number 888-773-9224, or simply fire off an email to shareholders@glancylaw.com for added guidance on your legal footing.
Unravel the financial intricacies as they unfold by tuning in to the updates from Glancy Prongay & Murray LLP on their LinkedIn, Twitter, or Facebook feeds.
Remember, this press release may tread the fine line of Attorney Advertising in some jurisdictions, adhering to all applicable laws and ethical standards.
Market News and Data brought to you by Benzinga APIs
